Zenas BioPharma Announces Key 2024 Accomplishments and 2025 Business Objectives
– Advancing Phase 2 and Phase 3 trials of obexelimab, a unique CD-19 x FcγRIIb inhibitor of B cell function- -Topline results from Phase 2 Read More
– Advancing Phase 2 and Phase 3 trials of obexelimab, a unique CD-19 x FcγRIIb inhibitor of B cell function- -Topline results from Phase 2 Read More
Perforator Yandex introduces Perforator, a tool that can identify and evaluate code inefficiencies across a company’s entire code base. Perforator helps Read More
Report finds that internet users have passed the 5.5 billion mark, with 136 million new users added in the last 12 months SAN FRANCISCO, Feb. 05, 2025 (Read More
Marketplace Reduces Payment Integration from 18 Months to Two Weeks BOSTON, Feb. 04, 2025 (GLOBE NEWSWIRE) — Duck Creek Technologies, the global intelligent solutions provider defining Read More
LM4 Platform Brings Affordable Management Automation to IDFs and Small Sites LM4 Out-of-Band Management Platform IRVINE, Calif., Feb. 04, 2025 (GLOBE NEWSWIRE) — Lantronix Inc. (Read More
Broker to showcase their capital allocation program, Axi Select, Manchester City memorabilia, and more SYDNEY, Feb. 04, 2025 (GLOBE NEWSWIRE) — Leading online FX and Read More
TAMPA, Fla., Feb. 03, 2025 (GLOBE NEWSWIRE) — AACSB International (AACSB) released a new report, GenAI Adoption in Business Schools: Deans and Faculty Respond, informed Read More
Copyright © 2025 All Reserved By ethiopianewsobserver.com